Adverse effects of long-term therapeutic doses of quinidine in asymptomatic Brugada patients: should low doses be used first?

Europace. 2014 Jul;16(7):1100. doi: 10.1093/europace/eut408. Epub 2014 Jan 23.

Authors

Manlio F Márquez¹, Joelci Tonet²

Affiliations

¹ Department of Electrophysiology, Instituto Nacional de Cardiología 'Ignacio Chávez', Juan Badiano 1, Sección XVI, Tlalpan, 14010 Mexico City, Mexico manlio.marquez@gmail.com.
² Rhythmology Unit, Hôpital Pitié-Salpêtrière, 47-83 Boulevard de l'Hôpital, 75651 Paris, France.

PMID: 24459248
DOI: 10.1093/europace/eut408

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Arrhythmia Agents / therapeutic use*
Brugada Syndrome / drug therapy*
Female
Humans
Male
Quinidine / analogs & derivatives*
Ventricular Fibrillation / prevention & control*

Substances

Anti-Arrhythmia Agents
Quinidine